Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Tenaya Therapeutics (TNYA)

Tenaya Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNYA
DateTimeSourceHeadlineSymbolCompany
02/05/202422:00GlobeNewswire Inc.Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TNYATenaya Therapeutics Inc
18/03/202420:05GlobeNewswire Inc.Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
18/03/202412:30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications MedicineNASDAQ:TNYATenaya Therapeutics Inc
28/02/202400:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNYATenaya Therapeutics Inc
27/02/202421:30GlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming March Investor ConferencesNASDAQ:TNYATenaya Therapeutics Inc
26/02/202413:30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature CommunicationsNASDAQ:TNYATenaya Therapeutics Inc
17/02/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNYATenaya Therapeutics Inc
17/02/202401:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TNYATenaya Therapeutics Inc
08/02/202422:25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNYATenaya Therapeutics Inc
08/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNYATenaya Therapeutics Inc
08/02/202413:00GlobeNewswire Inc.Tenaya Therapeutics Announces Pricing of Underwritten OfferingNASDAQ:TNYATenaya Therapeutics Inc
31/01/202421:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNYATenaya Therapeutics Inc
03/01/202413:30GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
21/11/202321:30GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
08/11/202321:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNYATenaya Therapeutics Inc
08/11/202321:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNYATenaya Therapeutics Inc
08/11/202321:05GlobeNewswire Inc.Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
26/10/202313:30GlobeNewswire Inc.Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
09/10/202313:30GlobeNewswire Inc.Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific MeetingNASDAQ:TNYATenaya Therapeutics Inc
05/10/202313:30GlobeNewswire Inc.Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
02/10/202322:30GlobeNewswire Inc.Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac RegenerationNASDAQ:TNYATenaya Therapeutics Inc
21/09/202321:05GlobeNewswire Inc.Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical ConferencesNASDAQ:TNYATenaya Therapeutics Inc
31/08/202321:05GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
18/08/202323:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNYATenaya Therapeutics Inc
17/08/202302:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TNYATenaya Therapeutics Inc
09/08/202321:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNYATenaya Therapeutics Inc
09/08/202321:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNYATenaya Therapeutics Inc
09/08/202321:05GlobeNewswire Inc.Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
02/08/202321:05GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth ConferenceNASDAQ:TNYATenaya Therapeutics Inc
10/05/202321:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TNYATenaya Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TNYA